Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-27

Clinical Trial Update: Indacaterol in Heart Failure Patients: Any Role on Lung Fluid Regulation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating indacaterol for heart failure; study completed with focus on lung fluid regulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indacaterol (indacaterol)

Snippet

Sponsor: Centro Cardiologico Monzino | Conditions: Heart Failure | Phase 3 | Status: COMPLETED